UK recommendations for HER2 assessment in breast cancer: an update
EA Rakha, PH Tan, C Quinn, E Provenzano… - Journal of clinical …, 2023 - jcp.bmj.com
The last UK breast cancer (BC) human epidermal growth factor receptor 2 (HER2) testing
guideline recommendations were published in 2015. Since then, new data and therapeutic …
guideline recommendations were published in 2015. Since then, new data and therapeutic …
Update on the use of molecular subtyping in breast cancer
TJ Lawton - Advances in Anatomic Pathology, 2023 - journals.lww.com
The standard of care for invasive cancers of the breast has been and continues to be to
evaluate them for breast prognostic markers: estrogen receptor, progesterone receptor, and …
evaluate them for breast prognostic markers: estrogen receptor, progesterone receptor, and …
[HTML][HTML] HSF1 Inhibits Antitumor Immune Activity in Breast Cancer by Suppressing CCL5 to Block CD8+ T-cell Recruitment
C Jacobs, S Shah, WC Lu, H Ray, J Wang… - Cancer Research, 2024 - AACR
Abstract Heat shock factor 1 (HSF1) is a stress-responsive transcription factor that promotes
cancer cell malignancy. To provide a better understanding of the biological processes …
cancer cell malignancy. To provide a better understanding of the biological processes …
[HTML][HTML] Prospective study of a diabetes risk reduction diet and the risk of breast cancer
Background Hyperinsulinemia and higher insulin-like growth factors may increase breast
cancer risk. We evaluated a diabetes risk reduction diet (DRRD) and breast cancer risk …
cancer risk. We evaluated a diabetes risk reduction diet (DRRD) and breast cancer risk …
Branched-chain amino acids and risk of breast cancer
OA Zeleznik, R Balasubramanian, Y Ren… - JNCI cancer …, 2021 - academic.oup.com
Background Circulating branched-chain amino acid (BCAA) levels reflect metabolic health
and dietary intake. However, associations with breast cancer are unclear. Methods We …
and dietary intake. However, associations with breast cancer are unclear. Methods We …
Identification, characterization, and prognosis investigation of pivotal genes shared in different stages of breast cancer
F Rommasi - Scientific Reports, 2023 - nature.com
One of the leading causes of death (20.1 per 100,000 women per year), breast cancer is the
most prevalent cancer in females. Statistically, 95% of breast cancer are categorized as …
most prevalent cancer in females. Statistically, 95% of breast cancer are categorized as …
Comparison of clinical subtypes of breast cancer within the Claudin-low molecular cluster reveals distinct phenotypes
IA Voutsadakis - Cancers, 2023 - mdpi.com
Simple Summary Breast cancer is not one homogeneous disease, but it includes many
subtypes that are identified in the clinical and research setting. The claudin-low subtype is a …
subtypes that are identified in the clinical and research setting. The claudin-low subtype is a …
Investigation of the role of PUFA metabolism in breast cancer using a rank-based random forest algorithm
Simple Summary Polyunsaturated fatty acids (PUFAs) and their derivatives, oxylipins, are a
constant focus of cancer research due to the relationship between cancer and processes of …
constant focus of cancer research due to the relationship between cancer and processes of …
Intrinsic subtypes in Ethiopian breast cancer patient
Z Desalegn, M Yohannes, M Porsch… - Breast Cancer Research …, 2022 - Springer
Purpose The recent development of multi-gene assays for gene expression profiling has
contributed significantly to the understanding of the clinically and biologically …
contributed significantly to the understanding of the clinically and biologically …
[HTML][HTML] Molecular subtyping improves breast cancer diagnosis in the Copenhagen Breast Cancer Genomics Study
BACKGROUND Intrinsic molecular subtypes define distinct biological breast cancers and
can be used to further improve diagnosis and risk allocation. METHODS The Copenhagen …
can be used to further improve diagnosis and risk allocation. METHODS The Copenhagen …